Lifeward (LFWD) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
Lifeward (LFWD) Net Income towards Common Stockholders Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 17.54% |
| 10 | Lifeward | 20.11 Mn | 10.66 Mn | 2.71 Mn | -35.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.68% |
| Dec 31, 2025 | -0.22% |
| Sep 30, 2025 | 16.58% |
| Jun 30, 2025 | -13.86% |
| Mar 31, 2025 | -3.58% |
| Dec 31, 2024 | -58.21% |
| Sep 30, 2024 | -4.86% |
| Jun 30, 2024 | -11.07% |
| Mar 31, 2024 | -27.03% |
| Dec 31, 2023 | -24.18% |
| Sep 30, 2023 | -31.18% |
| Jun 30, 2023 | -17.59% |
| Mar 31, 2023 | -4.01% |
| Dec 31, 2022 | -14.12% |
| Sep 30, 2022 | -17.23% |
| Jun 30, 2022 | 1.04% |
| Mar 31, 2022 | -2.84% |
| Dec 31, 2021 | -370.67% |
| Sep 30, 2021 | 16.12% |
| Jun 30, 2021 | 18.48% |